OrganiGram Holdings Inc.

TSX:OGI.TO

Drug Manufacturers - Specialty & Generic

Healthcare
$0.96 -1.43%

-$0.02 today

Market cap
$135.37M
Beta
1.84
P/E (TTM)
-7.2
EPS (TTM)
-$0.19
52W Low $1.37High $3.09

Volume 0.54M

Average 0.19M

OGI.TO Depreciation & Amortization

Non-cash expense that spreads the cost of physical and intangible assets over their useful lives.

OrganiGram Holdings Inc.TSX: OGI.TO

Depreciation & Amortization · Q2 FY2026 · quarter ended Mar 2026

Depreciation & amortization grows, but more slowly than its trailing trend

Q2 FY2026 depreciation & amortization of CA$5.03M rose 4.0% year over year, behind the +37.8% change in trailing-twelve-month depreciation & amortization. Sequentially, it rose 1.1% from the prior quarter.

Context

  • Depreciation & amortization amounted to 6.9% of revenue in FY2025, down 0.6 pp from a year earlier.
  • Depreciation & amortization increased in 1 of the last 3 fiscal years.

What to watch

Whether quarterly growth recovers from +4.0% toward the trailing-twelve-month pace of +37.8%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
CA$5.03M+1.1% QoQ
Last fiscal yearSep 2025
CA$17.98M+48.8% YoY
LTMMar 2026
CA$19.76M+37.8% YoY
Depreciation & Amortization past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+4.0%——
1 year+48.8%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Depreciation & Amortization history

CAD · from the income statement

Latest · FY2025
17.98M CAD
Year-over-year change
+48.8%
4-year CAGR
-12.8%

Depreciation & Amortization vs competitors

How OGI.TO compares with its peers on the latest reported figures

  • Peers report in different currencies, so depreciation & amortization is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +37.8% is the 2nd highest of 10, against a peer median of -0.8%.
  • Depreciation & amortization amounts to 7.2% of revenue for OGI.TO, versus a peer median of 6.8%.
OGI.TO Competitors
Depreciation & Amortization for OGI.TO and competitors
Company Period LTM YoY 3-year CAGR% of revenue
WEED.TOCanopy Growth CorporationLTM Mar 2026CA$40.12M CAD-6.9%-23.0%12.9%
HLS.TOHLS Therapeutics Inc.LTM Mar 2026$21.99M USD-0.8%-13.6%39.4%
OGI.TOOrganiGram Holdings Inc.LTM Mar 2026CA$19.76M CAD+37.8%—7.2%
TSND.TOTerrAscend Corp.LTM Mar 2026$16.18M USD-28.9%-10.7%6.2%
DR.TOMedical Facilities CorporationLTM Mar 2026$13.77M USD-26.6%-16.9%4.5%
ACB.TOAurora Cannabis Inc.LTM Mar 2026CA$13.39M CAD-40.6%-31.2%4.2%
XLY.TOAuxly Cannabis Group Inc.LTM Mar 2026CA$11.86M CAD+14.9%-17.2%7.5%
CPH.TOCipher Pharmaceuticals Inc.LTM Mar 2026$7.19M USD+29.5%+94.1%14.1%
EPRX.TOEupraxia Pharmaceuticals Inc.LTM Mar 2026$266.27K USD+72.6%+7.8%—
FRX.TOFennec Pharmaceuticals Inc.LTM Mar 2026$128K USD+24.3%-11.6%0.3%
Peer median (excluding OGI.TO) —-0.8%-13.6%6.8%

Competitors are the stored peer set for OGI.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

CAD
Metric
FY2021
Aug 2021
FY2022
Aug 2022
FY2023
Sep 2023
FY2024
Sep 2024
FY2025
Sep 2025
Revenue79.16M145.81M149.21M159.84M259.18M
Cost of Revenue107.56M114.24M114.13M112.32M249.67M
Gross Profit(28.4M)31.57M35.07M47.52M9.51M
Gross Margin-35.9%21.7%23.5%29.7%3.7%
Research & Development3.45M5.96M12.19M11.2M10.95M
Selling, General & Admin46.52M59.21M71.68M68.14M86.88M
Operating Expenses63.42M70.32M277.81M83.2M97.82M
Depreciation & Amortization31.03M24.91M24.17M12.08M17.98M
EBITDA(95.59M)10.97M(207.62M)(23.59M)(20.55M)
EBITDA Margin-120.8%7.5%-139.2%-14.8%-7.9%
Operating Income(91.82M)(43.15M)(242.74M)(35.67M)(88.31M)
Operating Margin-116.0%-29.6%-162.7%-22.3%-34.1%
Interest Income003.69M3.31M1.15M
Interest Expense2.96M429K277.85K00
Other Income / Expenses(38.88M)28.78M9.74M(9.77M)49.78M
Income Before Tax(130.7M)(14.37M)(233M)(45.44M)(38.53M)
Pre-Tax Margin-165.1%-9.9%-156.2%-28.4%-14.9%
Income Tax Expense0(88K)(3.52M)(5.28M)(13.77M)
Net Income(130.7M)(14.28M)(229.48M)(45.44M)(24.76M)
Net Margin-165.1%-9.8%-153.8%-28.4%-9.6%
EPS (Basic)(2.04)(0.18)(2.82)(0.48)(0.19)
EPS (Diluted)(2.04)(0.18)(2.82)(0.48)(0.19)
Weighted Avg Shares64.03M77.23M81.29M95.29M127.67M
Weighted Avg Shares (Diluted)64.03M77.23M81.29M95.29M127.67M

OrganiGram Holdings Inc.

TSX:OGI.TO

Intrinsic Alpha fair value

Locked

Current Price

$0.96

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.